The huPBL-SCID mouse as a means to examine human immune function in vivo

William J Murphy, Dennis D. Taub, Dan L. Longo

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The transfer of human peripheral blood Lymphocytes (huPBL) into mice with severe combined immune deficiency (SCID) has allowed for the generation of a model in which it is possible to examine human immune cell function in vivo. This model also provides the researcher an invaluable tool with which to examine human disease states and to evaluate potential therapies using human cells and reagents under more physiological conditions. However, it is clear that there are still significant obstacles that need to be addressed to optimize this model. The primary problem with the huPBL-SCID mouse is the tremendous variability in the extent of human cell engraftment which can vary from donor to donor and even from mouse to mouse using the same huPBL donor. This variability currently limits attempts to standardize this model among investigators and subsequently, various laboratories have employed different methods to optimize and ascertain the extent of human cell engraftment. In addition, there appears to be significant xenogeneic host-versus-graft and graft-versus-host reactions, as well as lethal EBV-induced B-cell lymphomas that can spontaneously arise which may further complicate the interpretation of human immunological studies performed in these mice. Despite these obstacles, the huPBL-SCID model has the potential to serve as a model for the examination of human lymphoid cells in an in-vivo setting and has been usefully applied to the study of various human disease states including AIDS, transplantations, autoimmunity and cancer.

Original languageEnglish (US)
Pages (from-to)233-241
Number of pages9
JournalSeminars in Immunology
Volume8
Issue number4
DOIs
StatePublished - Aug 1996
Externally publishedYes

Fingerprint

Severe Combined Immunodeficiency
Lymphocytes
Research Personnel
Tissue Donors
Transplants
B-Cell Lymphoma
Blood Donors
Autoimmunity
Human Herpesvirus 4
Acquired Immunodeficiency Syndrome

Keywords

  • Chimera
  • Human
  • Immune
  • Lymphocytes
  • SCID
  • Xenogeneic

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology

Cite this

The huPBL-SCID mouse as a means to examine human immune function in vivo. / Murphy, William J; Taub, Dennis D.; Longo, Dan L.

In: Seminars in Immunology, Vol. 8, No. 4, 08.1996, p. 233-241.

Research output: Contribution to journalArticle

Murphy, William J ; Taub, Dennis D. ; Longo, Dan L. / The huPBL-SCID mouse as a means to examine human immune function in vivo. In: Seminars in Immunology. 1996 ; Vol. 8, No. 4. pp. 233-241.
@article{fcc4ac803e104b20891bc8afe2f3c579,
title = "The huPBL-SCID mouse as a means to examine human immune function in vivo",
abstract = "The transfer of human peripheral blood Lymphocytes (huPBL) into mice with severe combined immune deficiency (SCID) has allowed for the generation of a model in which it is possible to examine human immune cell function in vivo. This model also provides the researcher an invaluable tool with which to examine human disease states and to evaluate potential therapies using human cells and reagents under more physiological conditions. However, it is clear that there are still significant obstacles that need to be addressed to optimize this model. The primary problem with the huPBL-SCID mouse is the tremendous variability in the extent of human cell engraftment which can vary from donor to donor and even from mouse to mouse using the same huPBL donor. This variability currently limits attempts to standardize this model among investigators and subsequently, various laboratories have employed different methods to optimize and ascertain the extent of human cell engraftment. In addition, there appears to be significant xenogeneic host-versus-graft and graft-versus-host reactions, as well as lethal EBV-induced B-cell lymphomas that can spontaneously arise which may further complicate the interpretation of human immunological studies performed in these mice. Despite these obstacles, the huPBL-SCID model has the potential to serve as a model for the examination of human lymphoid cells in an in-vivo setting and has been usefully applied to the study of various human disease states including AIDS, transplantations, autoimmunity and cancer.",
keywords = "Chimera, Human, Immune, Lymphocytes, SCID, Xenogeneic",
author = "Murphy, {William J} and Taub, {Dennis D.} and Longo, {Dan L.}",
year = "1996",
month = "8",
doi = "10.1006/smim.1996.0029",
language = "English (US)",
volume = "8",
pages = "233--241",
journal = "Seminars in Immunology",
issn = "1044-5323",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - The huPBL-SCID mouse as a means to examine human immune function in vivo

AU - Murphy, William J

AU - Taub, Dennis D.

AU - Longo, Dan L.

PY - 1996/8

Y1 - 1996/8

N2 - The transfer of human peripheral blood Lymphocytes (huPBL) into mice with severe combined immune deficiency (SCID) has allowed for the generation of a model in which it is possible to examine human immune cell function in vivo. This model also provides the researcher an invaluable tool with which to examine human disease states and to evaluate potential therapies using human cells and reagents under more physiological conditions. However, it is clear that there are still significant obstacles that need to be addressed to optimize this model. The primary problem with the huPBL-SCID mouse is the tremendous variability in the extent of human cell engraftment which can vary from donor to donor and even from mouse to mouse using the same huPBL donor. This variability currently limits attempts to standardize this model among investigators and subsequently, various laboratories have employed different methods to optimize and ascertain the extent of human cell engraftment. In addition, there appears to be significant xenogeneic host-versus-graft and graft-versus-host reactions, as well as lethal EBV-induced B-cell lymphomas that can spontaneously arise which may further complicate the interpretation of human immunological studies performed in these mice. Despite these obstacles, the huPBL-SCID model has the potential to serve as a model for the examination of human lymphoid cells in an in-vivo setting and has been usefully applied to the study of various human disease states including AIDS, transplantations, autoimmunity and cancer.

AB - The transfer of human peripheral blood Lymphocytes (huPBL) into mice with severe combined immune deficiency (SCID) has allowed for the generation of a model in which it is possible to examine human immune cell function in vivo. This model also provides the researcher an invaluable tool with which to examine human disease states and to evaluate potential therapies using human cells and reagents under more physiological conditions. However, it is clear that there are still significant obstacles that need to be addressed to optimize this model. The primary problem with the huPBL-SCID mouse is the tremendous variability in the extent of human cell engraftment which can vary from donor to donor and even from mouse to mouse using the same huPBL donor. This variability currently limits attempts to standardize this model among investigators and subsequently, various laboratories have employed different methods to optimize and ascertain the extent of human cell engraftment. In addition, there appears to be significant xenogeneic host-versus-graft and graft-versus-host reactions, as well as lethal EBV-induced B-cell lymphomas that can spontaneously arise which may further complicate the interpretation of human immunological studies performed in these mice. Despite these obstacles, the huPBL-SCID model has the potential to serve as a model for the examination of human lymphoid cells in an in-vivo setting and has been usefully applied to the study of various human disease states including AIDS, transplantations, autoimmunity and cancer.

KW - Chimera

KW - Human

KW - Immune

KW - Lymphocytes

KW - SCID

KW - Xenogeneic

UR - http://www.scopus.com/inward/record.url?scp=0343647206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343647206&partnerID=8YFLogxK

U2 - 10.1006/smim.1996.0029

DO - 10.1006/smim.1996.0029

M3 - Article

C2 - 8883146

AN - SCOPUS:0343647206

VL - 8

SP - 233

EP - 241

JO - Seminars in Immunology

JF - Seminars in Immunology

SN - 1044-5323

IS - 4

ER -